FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FATE is currently covered by 7 analysts with an average price target of $11.29. This is a potential upside of $9.82 (668.03%) from yesterday's end of day stock price of $1.47.

Fate Therapeutics's activity chart (see below) currently has 291 price targets and 200 ratings on display. The stock rating distribution of FATE is 77.78% HOLD and 22.22% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.93% with an average time for these price targets to be met of 145.13 days.

Highest price target for FATE is $5, Lowest price target is $2, average price target is $3.25.

Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 12-Aug-2025.

Currently out of the existing stock ratings of FATE, 7 are a HOLD (77.78%), 2 are a BUY (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2.5

$1.03 (70.07%)

$4

2 months 7 days ago
(12-Aug-2025)

2/4 (50%)

$1.37 (121.24%)

49

Buy

$2

$0.53 (36.05%)

$6

5 months 6 days ago
(13-May-2025)

6/8 (75%)

$1.04 (108.33%)

91

Hold

$4

$2.53 (172.11%)

$28

5 months 6 days ago
(13-May-2025)

1/2 (50%)

$3.04 (316.67%)

33

Hold

$3

$1.53 (104.08%)

7 months 10 days ago
(09-Mar-2025)

2/4 (50%)

$2.07 (222.58%)

111

Buy

$145

7 months 14 days ago
(05-Mar-2025)

0/1 (0%)

$52.99 (57.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 145.13 days on average for the stock forecasts to be realized with a an average price target met ratio 59.93

Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Biren Amin with highest potential upside - $107.53

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Jim Birchenough with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?